ACON | Aclarion, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.1750 - 0.1800
52 Week Range	0.1600 - 7.39
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	119,064
Average Volume	469,004
Shares Outstanding	10,431,159
Market Cap	1,831,712
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2022-04-22

Valuation
Profitability
Growth
Health
P/E Ratio	-0.07
Forward P/E Ratio	N/A
EPS	-2.40
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	4
Country	USA
Website	ACON

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.

ACON's peers: OPRX, SY, EUDA, FOXO, AUGX, ETAO, AKLI, HCTI, MGRX, HSTM, NRC, FORA, ACONW, WGS, BFRG

*Chart delayed

Analyzing fundamentals for ACON we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see ACON Fundamentals page.

Watching at ACON technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on ACON Technicals page.